fig3

Clinical significance of cytokeratin 19 expression in hepatocellular carcinoma

Figure 3. Subgroup analyses of recurrence-free survival (A) and overall survival (B). Shared clinicopathological characteristics of CK19-positive and CK19 patients were thoroughly examined. CK19: Cytokeratin 19.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/